Related Experiment Video
Updated: Aug 2, 2026

06:54
Author Spotlight: Advancements in Impedance Monitoring for Cochlear Implant Surgery
Published on: August 4, 2023
1.1K
Photobiomodulation as a Potential Adjuvant Therapy to Improve Cochlear Implant Efficiency
So-Young Chang1, Min Young Lee2,3
1Beckman Laser Institute Korea, Dankook University, Cheonan, Republic of Korea.
Photobiomodulation, Photomedicine, and Laser Surgery
|September 30, 2024
Summary
Photobiomodulation (PBM) may reduce inflammation and nerve damage after cochlear implantation. This noninvasive therapy could improve hearing outcomes for patients with hearing loss.
Area of Science:
- Regenerative Medicine
- Otolaryngology
- Biomedical Engineering
Background:
- Hearing loss is irreversible in mammals due to limited cochlear hair cell regeneration.
- Cochlear implants (CI) bypass damaged hair cells but can cause inflammation and nerve damage.
- Existing strategies to minimize secondary cochlear damage post-CI are being investigated.
Purpose of the Study:
- To review current strategies for minimizing cochlear damage after cochlear implantation.
- To evaluate the potential of photobiomodulation (PBM) as an adjuvant therapy for cochlear implantation.
- To explore PBM's neuroprotective effects for enhancing auditory function.
Main Methods:
- Literature review of PBM applications in biological processes.
- Analysis of PBM's effects on inflammation and tissue recovery.
- Examination of PBM's potential to protect auditory cells and nerve fibers.
Main Results:
- PBM reduces inflammation and enhances tissue recovery through various pathways.
- PBM demonstrates potential for protecting auditory cells, possibly improving hearing outcomes with EAS devices.
- Postoperative CI is associated with an inflammatory response involving cytokine upregulation.
Conclusions:
- PBM shows promise as a neuroprotective strategy to mitigate secondary cochlear damage after implantation.
- Further validation is needed for PBM's application in enhancing cochlear implant efficacy.
- PBM's neuroregenerative potential could benefit patients with residual hearing undergoing cochlear implantation.

